KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) EBIT Margin (2016 - 2026)

Globus Medical filings provide 15 years of EBIT Margin readings, the most recent being 20.49% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 1132.0% to 20.49% in Q4 2025 year-over-year; TTM through Dec 2025 was 16.33%, a 974.0% increase, with the full-year FY2025 number at 16.33%, up 974.0% from a year prior.
  • EBIT Margin hit 20.49% in Q4 2025 for Globus Medical, up from 17.86% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 25.71% in Q2 2022 to a low of 0.11% in Q3 2023.
  • Median EBIT Margin over the past 5 years was 18.07% (2021), compared with a mean of 14.87%.
  • Biggest five-year swings in EBIT Margin: skyrocketed 3544bps in 2021 and later tumbled -2339bps in 2023.
  • Globus Medical's EBIT Margin stood at 7.28% in 2021, then surged by 170bps to 19.68% in 2022, then plummeted by -92bps to 1.64% in 2023, then skyrocketed by 458bps to 9.17% in 2024, then soared by 123bps to 20.49% in 2025.
  • The last three reported values for EBIT Margin were 20.49% (Q4 2025), 17.86% (Q3 2025), and 10.21% (Q2 2025) per Business Quant data.